Haemonetics (HAE) Income from Continuing Operations (2009 - 2026)
Haemonetics (HAE) posted quarterly Income from Continuing Operations of 20147000.0 for Q1 2026, down 134.75% year-over-year from 57981000.0 in Q1 2025, and down 145.03% quarter-over-quarter from 44740000.0 in Q4 2025.
Haemonetics (HAE) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Haemonetics' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 20147000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 134.75% year-over-year to 20147000.0; the TTM figure through Mar 2026 stood at 97347000.0 (down 41.95% YoY), while the FY2026 annual figure was 97308000.0, down 41.97% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 20147000.0, down from 44740000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 57981000.0 in Q1 2025, with the low at 20147000.0 in Q1 2026.
- The 5-year median for Income from Continuing Operations is 33051500.0 (2022), against an average of 29502888.89.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations soared 546.27% in 2022, then plunged 134.75% in 2026.
- Haemonetics' Income from Continuing Operations stood at 32944000.0 in 2022, then fell by 5.17% to 31241000.0 in 2023, then rose by 20.09% to 37517000.0 in 2024, then rose by 19.25% to 44740000.0 in 2025, then sank by 145.03% to 20147000.0 in 2026.
- Business Quant data shows HAE's Income from Continuing Operations at 20147000.0 in Q1 2026, 44740000.0 in Q4 2025, and 38685000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | 820.63 Mn |
| 10 | Haemonetics | 4.77 Bn | 4.55 Bn | 202.80 Mn | 32.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 32.97 Mn |
| Mar 28, 2026 | -20.15 Mn |
| Dec 27, 2025 | 44.74 Mn |
| Sep 27, 2025 | 38.69 Mn |
| Jun 28, 2025 | 34.07 Mn |
| Mar 29, 2025 | 57.98 Mn |
| Dec 28, 2024 | 37.52 Mn |
| Sep 28, 2024 | 33.83 Mn |
| Jun 29, 2024 | 38.37 Mn |
| Mar 30, 2024 | 20.41 Mn |
| Dec 30, 2023 | 31.24 Mn |
| Sep 30, 2023 | 24.93 Mn |
| Jul 1, 2023 | 41.09 Mn |
| Apr 1, 2023 | 29.42 Mn |
| Dec 31, 2022 | 32.94 Mn |
| Oct 1, 2022 | 33.16 Mn |
| Jul 2, 2022 | 19.88 Mn |
| Apr 2, 2022 | 9.74 Mn |
| Jan 1, 2022 | 23.19 Mn |
| Oct 2, 2021 | 14.82 Mn |